See also: Further information Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances
E., Dunleavy, M
What Are the Benefits of Leucine
IM: Writing review & editing, Validation
Discovery of BMS-986318, a potent nonbile acid FXR agonist for the treatment of nonalcoholic steatohepatitis
According to DSM-5 criteria,[] a patient is required to fulfill all the three primary criteria (exposure to the dopamine-blocking agent, severe muscle rigidity, and fever) and at least two other measures (diaphoresis, dysphagia, tremor, incontinence, altered level of consciousness, mutism, tachycardia, elevated or labile blood pressure, leukocytosis, and elevated creatine phosphokinase)